These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8913268)

  • 1. Effect of N-(4-hydroxyphenyl)retinamide on apoptosis in human breast cancer cells.
    Wang TT; Phang JM
    Cancer Lett; 1996 Oct; 107(1):65-71. PubMed ID: 8913268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis.
    Shen JC; Wang TT; Chang S; Hursting SD
    Mol Carcinog; 1999 Mar; 24(3):160-8. PubMed ID: 10204800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.
    Boya P; Morales MC; Gonzalez-Polo RA; Andreau K; Gourdier I; Perfettini JL; Larochette N; Deniaud A; Baran-Marszak F; Fagard R; Feuillard J; Asumendi A; Raphael M; Pau B; Brenner C; Kroemer G
    Oncogene; 2003 Sep; 22(40):6220-30. PubMed ID: 13679861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2.
    Delia D; Aiello A; Formelli F; Fontanella E; Costa A; Miyashita T; Reed JC; Pierotti MA
    Blood; 1995 Jan; 85(2):359-67. PubMed ID: 7811993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells.
    Darwiche N; Hatoum A; Dbaibo G; Kadara H; Nasr R; Abou-Lteif G; Bazzi R; Hermine O; de Thé H; Bazarbachi A
    Leukemia; 2004 Mar; 18(3):607-15. PubMed ID: 14712289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of N-(4-hydroxyphenyl)retinamide-induced apoptosis in breast cancer cells by galectin-3.
    Choi JH; Chun KH; Raz A; Lotan R
    Cancer Biol Ther; 2004 May; 3(5):447-52. PubMed ID: 15326375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
    Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T
    Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL).
    Faderl S; Lotan R; Kantarjian HM; Harris D; Van Q; Estrov Z
    Leuk Res; 2003 Mar; 27(3):259-66. PubMed ID: 12537979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells.
    Das A; Banik NL; Ray SK
    Brain Res; 2008 Aug; 1227():207-15. PubMed ID: 18602901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-oxo-N-(4-hydroxyphenyl)retinamide: two independent ways to kill cancer cells.
    Tiberio P; Cavadini E; Abolafio G; Formelli F; Appierto V
    PLoS One; 2010 Oct; 5(10):e13362. PubMed ID: 20976277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action.
    Takahashi N; Watanabe Y; Maitani Y; Yamauchi T; Higashiyama K; Ohba T
    Int J Cancer; 2008 Feb; 122(3):689-98. PubMed ID: 17955489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
    Favoni RE; de Cupis A; Bruno S; Yee D; Ferrera A; Pirani P; Costa A; Decensi A
    Br J Cancer; 1998 Jun; 77(12):2138-47. PubMed ID: 9649125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.
    Simeone AM; Deng CX; Kelloff GJ; Steele VE; Johnson MM; Tari AM
    Carcinogenesis; 2005 May; 26(5):1000-7. PubMed ID: 15695235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP
    J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
    Kazmi SM; Plante RK; Visconti V; Lau CY
    Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
    Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
    Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line.
    Holmes WF; Soprano DR; Soprano KJ
    J Biol Chem; 2002 Nov; 277(47):45408-19. PubMed ID: 12237293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of aberrant proliferation and induction of apoptosis in HER-2/neu oncogene transformed human mammary epithelial cells by N-(4-hydroxyphenyl)retinamide.
    Jinno H; Steiner MG; Mehta RG; Osborne MP; Telang NT
    Carcinogenesis; 1999 Feb; 20(2):229-36. PubMed ID: 10069458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
    Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide.
    Chen YR; Zhou G; Tan TH
    Mol Pharmacol; 1999 Dec; 56(6):1271-9. PubMed ID: 10570055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.